Clinical Trials on Microalbuminuria Due to Type 2 Diabetes Mellitus in New Zealand
Total 1402 results
-
Edgar National Centre for Diabetes ResearchUniversity of OtagoUnknown
-
North Shore Hospital, New ZealandCompletedObesity | Type 2 Diabetes MellitusNew Zealand
-
Insulet CorporationCompleted
-
University of OtagoEdgar National Centre for Diabetes ResearchCompletedObesity | Type 2 Diabetes MellitusNew Zealand
-
Bispebjerg HospitalCompleted
-
Zhejiang Doer Biologics Co., Ltd.RecruitingHealthy, Obesity, MetabolicallyNew Zealand
-
Eli Lilly and CompanyCompletedType 2 DiabetesIndia, Mexico, New Zealand, South Africa
-
Christchurch HospitalUnknownDiabetes Mellitus, Type 2New Zealand
-
PfizerCompletedDiabetes Melliuts, Type 2United States
-
Zafgen, Inc.CompletedType 2 Diabetes Mellitus | Overweight and ObesityAustralia, New Zealand
-
Rutgers, The State University of New JerseyCompleted
-
Diatranz Otsuka LimitedCompleted
-
PfizerTerminated
-
vTv TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
PfizerCompletedType 2 Diabetes PatientsUnited States
-
Yale UniversityNational Center for Advancing Translational Sciences (NCATS)WithdrawnDiabete Type 2United States
-
PegBio Co., Ltd.CompletedType2 Diabetes MellitusUnited States
-
TakedaTerminatedType 2 Diabetes MellitusTaiwan, China, Korea, Republic of, New Zealand, Australia
-
Diabetes Foundation, IndiaNational Diabetes Obesity and Cholesterol FoundationRecruitingType 2 Diabetes Mellitus With ComplicationIndia
-
NYU Langone HealthTerminated
-
Northwell HealthPatient-Centered Outcomes Research InstituteCompletedType 2 Diabetes Mellitus | Type 2 DiabetesUnited States
-
Diabetes Foundation, IndiaIndian Council of Medical ResearchCompletedT2DM (Type 2 Diabetes Mellitus) | NormoglycemiaIndia
-
Albany Research Institute, Inc.Completed
-
ChemoCentryxCompletedType 2 Diabetes MellitusGermany, New Zealand, Hungary, Czechia, Australia
-
PfizerCompletedType 2 Diabetes MellitusUnited States
-
Boston TherapeuticsSugardown Company LimitedCompletedType2 Diabetes MellitusUnited States
-
New York Institute of TechnologyAmerican Osteopathic AssociationRecruitingType2 Diabetes Mellitus | Osteopathy in Diseases Classified ElsewhereUnited States
-
Christchurch Clinical Studies Trust LtdMedtronicUnknownType1diabetesNew Zealand
-
Blandine LaferrereMerck Sharp & Dohme LLCCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Mexico, India
-
Albert Einstein College of MedicineTakedaCompletedType 2 Diabetes MellitusUnited States
-
Valeritas, Inc.Integrated Medical DevelopmentCompletedType 2 Diabetes MellitusUnited States
-
TheracosCompletedType2 Diabetes MellitusUnited States, Japan
-
vTv TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
Max Healthcare Insititute LimitedCompletedType 2 Diabetes Mellitus in ObeseIndia
-
Suzhou Alphamab Co., Ltd.Novotech (Australia) Pty LimitedRecruiting
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Eli Lilly and CompanyActive, not recruitingGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Type2 Diabetes | Metabolic Disease | T2DM (Type 2 Diabetes Mellitus) | T2DUnited States, India, Australia, United Kingdom, Mexico, Brazil, Israel, France, Italy
-
Garvan Institute of Medical ResearchWeizmann Institute of ScienceActive, not recruitingType 2 Diabetes Mellitus | Pre DiabetesAustralia
-
Eli Lilly and CompanyTerminatedType 2 Diabetes MellitusUnited States
-
Sound Shore Medical Center of WestchesterMaffucci L, Rangraj MCompletedType 2 Diabetes MellitusUnited States
-
SanofiCompleted
-
Albert Einstein College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...RecruitingGlucose Metabolism Disorders | Type 2 Diabetes Mellitus | Glucose, High BloodUnited States
-
The Deutsche Diabetes Forschungsgesellschaft e.V.Algiax Pharmaceuticals GmbHRecruiting
-
PfizerCompletedType 2 Diabetes MellitusUnited States
-
German Diabetes CenterYale UniversityEnrolling by invitationType2 DiabetesGermany
-
NYU Langone HealthWashington University School of MedicineTerminatedPatients Who Consented to Undergo Laparoscopic Gastric Banding Surgery for Weight Loss and Consent to Participate in This studyBMI ≥35 kg/m2 | Confirmed Type 2 Diabetes Treated With Oral Agents and/or Only Diet Therapy | Age 18-64 YearsUnited States
-
Wellstat TherapeuticsCompletedType 2 Diabetes MellitusUnited States